Patents by Inventor Xiao Shi
Xiao Shi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20180012428Abstract: A method, a device, and a system for processing information of a vehicle are disclosed. In the embodiments, information about a connected vehicle is acquired, and a display image of a virtual vehicle is generated; driving information of the connected vehicle is acquired; whether the vehicle is currently in a driving state is determined according to the driving information; and when the connected vehicle is in the driving state, an orientation of a head of the virtual vehicle is adjusted to keep consistency with an orientation of a head of the connected vehicle; and when the connected vehicle is in a non-driving state, an orientation of a head of the virtual vehicle is adjusted towards a location of the connected vehicle. The present disclosure can feed back a vehicle condition in real time, dynamically and truly, and position a vehicle more accurately.Type: ApplicationFiled: September 20, 2017Publication date: January 11, 2018Applicant: Tencent Technology (ZSenzhen) Company LimitedInventors: Xiao SHI, Renhua Du, Qian Wang, Xiangdong Zhu, Qiqi Zhu, Le Zhang, Wei Wang
-
Publication number: 20160215363Abstract: Provided is a backflow cascade novel process for producing a lithium-7 isotope. The process comprises an upper backflow section, an extraction section, an enrichment section, a lower backflow section, and a product acquiring section. Upper backflow phase-conversion liquid and lower backflow phase-conversion liquid are respectively added to the upper backflow section and the lower backflow section, and upper backflow phase-conversion liquid and lower backflow phase-conversion liquid of the lithium material are controlled; the product is precisely acquired in the product acquiring section; an organic phase is added to the upper backflow section, and is recycled in the lower backflow section. By means of cascade connection with a high-performance liquid separator, environmental protection, high efficiency, and multi-level enrichment of the lithium-7 isotope are achieved, and a high-abundance lithium-7 isotope product is obtained.Type: ApplicationFiled: March 28, 2014Publication date: July 28, 2016Applicant: Shanghai Institute of Organic Chemistry, Chinese Academy of SciencesInventors: Jinbo Hu, Wei Zhang, Weiqin Zheng, Guanghua Chen, Xiao Shi, Yongchang Xu, Honggui Lv, Chengye Yuan
-
Patent number: 8933745Abstract: A transconductance-enhancing passive frequency mixer comprises a transconductance amplification stage, a frequency mixing stage, and an output transresistance amplifier. The transconductance amplification stage has a pre-amplification transconductance-enhancing structure, so that the transconductance is greatly enhanced, thereby obtaining the same transconductance value at a lower bias current. A radio-frequency current is modulated by the frequency mixing stage to generate an output mid-frequency current signal. The mid-frequency current signal passes through the transresistance amplifier, to form voltage output, and finally obtain a mid-frequency voltage signal. The transresistance amplifier has a transconductance-enhancing structure, thereby further reducing input impedance, and improving current utilization efficiency and port isolation. The frequency mixer has the characteristics of low power consumption, high conversion gain, good port isolation, and the like.Type: GrantFiled: May 29, 2012Date of Patent: January 13, 2015Assignee: Southeast UniversityInventors: Jianhui Wu, Xiao Shi, Chao Chen, Zhilin Liu, Qiang Zhao, Junfeng Wen, Xudong Wang, Chunfeng Bai, Qian Tian
-
Patent number: 8810440Abstract: A stochastic time-digital converter (STDC) including an input switching circuit, an STDC array, and an encoder. A clock circuit inputs two clock signals into two input terminals of the input switching circuit; the input switching circuit transmits the two clock signals in a cyclic cross-transposition form to two input terminals of the STDC array, and simultaneously outputs a trigger control signal to the encoder; each comparator in the STDC array independently judges the speeds of the two clock signals and sends the judgement results to the encoder for collection and processing; and the encoder outputs the size and positivity or negativity of the phase difference of the two clock signals. The technical solution utilizes the stochastic characteristic of the STDC to double the number of the equivalent comparators in the STDC array, eliminating the effects on the circuitry of device mismatching and processes, power supply voltage, and temperature.Type: GrantFiled: May 29, 2012Date of Patent: August 19, 2014Assignee: Southeast UniversityInventors: Jianhui Wu, Zixuan Wang, Xiao Shi, Meng Zhang, Cheng Huang, Chao Chen, Fuqing Huang, Xincun Ji, Ping Jiang
-
Patent number: 8748174Abstract: The present invention provides novel MDCK-derived adherent non-tumorigenic cell lines that can be grown in the presence or absence of serum. The cell lines of the present invention are useful for the production of vaccine material (e.g., viruses). More specifically, the cell lines of the present invention are useful for the production of influenza viruses in general and ca/ts influenza viruses in particular. The invention further provides methods and media formulations for the adaptation and cultivation of MDCK cells such that they remain non-tumorigenic. Additionally, the present invention provides methods for the production of vaccine material (e.g., influenza virus) in the novel cell lines of the invention.Type: GrantFiled: January 20, 2012Date of Patent: June 10, 2014Assignee: MedImmune, LLCInventors: Richard Schwartz, John Michael Berry, Ajit Subramanian, Xiao Shi
-
Publication number: 20130307711Abstract: A stochastic time-digital converter (STDC) including an input switching circuit, an STDC array, and an encoder. A clock circuit inputs two clock signals into two input terminals of the input switching circuit; the input switching circuit transmits the two clock signals in a cyclic cross-transposition form to two input terminals of the STDC array, and simultaneously outputs a trigger control signal to the encoder; each comparator in the STDC array independently judges the speeds of the two clock signals and sends the judgement results to the encoder for collection and processing; and the encoder outputs the size and positivity or negativity of the phase difference of the two clock signals. The technical solution utilizes the stochastic characteristic of the STDC to double the number of the equivalent comparators in the STDC array, eliminating the effects on the circuitry of device mismatching and processes, power supply voltage, and temperature.Type: ApplicationFiled: May 29, 2012Publication date: November 21, 2013Applicant: SOUTHEAST UNIVERSITYInventors: Jianhui Wu, Zixuan Wang, Xiao Shi, Meng Zhang, Cheng Huang, Chao Chen, Fuqing Huang, Xincun Ji, Ping Jiang
-
Publication number: 20130285715Abstract: A transconductance-enhancing passive frequency mixer comprises a transconductance amplification stage, a frequency mixing stage, and an output transresistance amplifier. The transconductance amplification stage has a pre-amplification transconductance-enhancing structure, so that the transconductance is greatly enhanced, thereby obtaining the same transconductance value at a lower bias current. A radio-frequency current is modulated by the frequency mixing stage to generate an output mid-frequency current signal. The mid-frequency current signal passes through the transresistance amplifier, to form voltage output, and finally obtain a mid-frequency voltage signal. The transresistance amplifier has a transconductance-enhancing structure, thereby further reducing input impedance, and improving current utilization efficiency and port isolation. The frequency mixer has the characteristics of low power consumption, high conversion gain, good port isolation, and the like.Type: ApplicationFiled: May 29, 2012Publication date: October 31, 2013Applicant: Southeast UniversityInventors: Jianhui Wu, Xiao Shi, Chao Chen, Zhilin Liu, Qiang Zhao, Junfeng Wen, Xudong Wang, Chunfeng Bai, Qian Tian
-
Publication number: 20120115206Abstract: The present invention provides novel MDCK-derived adherent non-tumorigenic cell lines that can be grown in the presence or absence of serum. The cell lines of the present invention are useful for the production of vaccine material (e.g., viruses). More specifically, the cell lines of the present invention are useful for the production of influenza viruses in general and ca/ts influenza viruses in particular. The invention further provides methods and media formulations for the adaptation and cultivation of MDCK cells such that they remain non-tumorigenic. Additionally, the present invention provides methods for the production of vaccine material (e.g., influenza virus) in the novel cell lines of the invention.Type: ApplicationFiled: January 20, 2012Publication date: May 10, 2012Applicant: Medlmmune WayInventors: Richard Schwartz, John Michael Berry, Ajit Subramanian, Xiao Shi
-
Patent number: 8119388Abstract: The present invention provides novel MDCK-derived adherent non-tumorigenic cell lines that can be grown in the presence or absence of serum. The cell lines of the present invention are useful for the production of vaccine material (e.g., viruses). More specifically, the cell lines of the present invention are useful for the production of influenza viruses in general and ca/ts influenza viruses in particular. The invention further provides methods and media formulations for the adaptation and cultivation of MDCK cells such that they remain non-tumorigenic. Additionally, the present invention provides methods for the production of vaccine material (e.g., influenza virus) in the novel cell lines of the invention.Type: GrantFiled: January 13, 2010Date of Patent: February 21, 2012Assignee: Medimmune, LLCInventors: Richard Schwartz, John Michael Berry, Ajit Subramanian, Xiao Shi
-
Publication number: 20100112000Abstract: The present invention provides novel MDCK-derived adherent non-tumorigenic cell lines that can be grown in the presence or absence of serum. The cell lines of the present invention are useful for the production of vaccine material (e.g., viruses). More specifically, the cell lines of the present invention are useful for the production of influenza viruses in general and ca/ts influenza viruses in particular. The invention further provides methods and media formulations for the adaptation and cultivation of MDCK cells such that they remain non-tumorigenic. Additionally, the present invention provides methods for the production of vaccine material (e.g., influenza virus) in the novel cell lines of the invention.Type: ApplicationFiled: January 13, 2010Publication date: May 6, 2010Applicant: MEDIMMUNE, LLCInventors: Richard SCHWARTZ, John Michael Berry, Ajit SUBRAMANIAN, Xiao SHI
-
Patent number: 7670837Abstract: The present invention provides novel MDCK-derived adherent non-tumorigenic cell lines that can be grown in the presence or absence of serum. The cell lines of the present invention are useful for the production of vaccine material (e.g., viruses). More specifically, the cell lines of the present invention are useful for the production of influenza viruses in general and ca/ts influenza viruses in particular. The invention further provides methods and media formulations for the adaptation and cultivation of MDCK cells such that they remain non-tumorigenic. Additionally, the present invention provides methods for the production of vaccine material (e.g., influenza virus) in the novel cell lines of the invention.Type: GrantFiled: December 16, 2005Date of Patent: March 2, 2010Assignee: Medimmune, LLCInventors: Richard Schwartz, John Michael Berry, Ajit Subramanian, Xiao Shi
-
Publication number: 20060188977Abstract: The present invention provides novel MDCK-derived adherent non-tumorigenic cell lines that can be grown in the presence or absence of serum. The cell lines of the present invention are useful for the production of vaccine material (e.g., viruses). More specifically, the cell lines of the present invention are useful for the production of influenza viruses in general and ca/ts influenza viruses in particular. The invention further provides methods and media formulations for the adaptation and cultivation of MDCK cells such that they remain non-tumorigenic. Additionally, the present invention provides methods for the production of vaccine material (e.g., influenza virus) in the novel cell lines of the invention.Type: ApplicationFiled: December 16, 2005Publication date: August 24, 2006Applicant: MEDIMMUNE VACCINES, INC.Inventors: Richard Schwartz, John Berry, Ajit Subramanian, Xiao Shi
-
Patent number: 5341744Abstract: An apparatus for cleaning the bore of a firearm including a shell housing having a rearwardly oriented base portion, a substantially tubular body defining a cavity, and a forward end, a tank for confining a compressed fluid, the tank being disposed within the cavity of the housing, a cleaning wad for cleaning the bore of the firearm, disposed forward of the tank, and a rupturing member disposed between the tank and the cleaning wad, whereby the compressed fluid is released from the tank and propels the cleaning wad through the bore of the firearm.Type: GrantFiled: February 22, 1993Date of Patent: August 30, 1994Inventor: Xiao Shi